Metabolic encephalopathies in the critical care unit

CONTINUUM Lifelong Learning in Neurology

Volumn 18, Issue 3, 2012, Pages 611-639

  Frontera, Jennifer A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BENZODIAZEPINE; CARBON MONOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYANIDE; CYANOCOBALAMIN; ETHYLENE GLYCOL; ETIRACETAM; FOLIC ACID; LEAD; METHANOL; NEUROTRANSMITTER; NICOTINIC ACID; OPIATE; ORGANOPHOSPHATE; PARACETAMOL; SALICYLIC ACID; SEDATIVE AGENT; TOXIN; VALPROIC ACID;

ADRENAL INSUFFICIENCY; ALCOHOL WITHDRAWAL; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN INFECTION; BRAIN INJURY; CEREBRAL SINUS THROMBOSIS; CLINICAL ASSESSMENT TOOL; COGNITION; CONFUSION ASSESSMENT METHOD FOR THE INTENSIVE CARE UNIT; CONSCIOUSNESS LEVEL; CRITICALLY ILL PATIENT; CYANOCOBALAMIN DEFICIENCY; DEGENERATIVE DISEASE; DELIRIUM; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; ELECTROLYTE DISTURBANCE; FOLIC ACID DEFICIENCY; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERCALCEMIA; HYPERCAPNIA; HYPERGLYCEMIA; HYPERMAGNESEMIA; HYPERNATREMIA; HYPERPARATHYROIDISM; HYPERTENSIVE CRISIS; HYPERTHYROIDISM; HYPERVISCOSITY SYNDROME; HYPOCALCEMIA; HYPOGLYCEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOPARATHYROIDISM; HYPOPHOSPHATEMIA; HYPOTHYROIDISM; HYPOXEMIA; INBORN ERROR OF METABOLISM; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE MONITORING; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG INSUFFICIENCY; MARCHIAFAVA BIGNAMI DISEASE; MENTAL DISEASE; METABOLIC ENCEPHALOPATHY; MORTALITY; MYOCLONUS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROCHEMISTRY; NEUROLOGIC EXAMINATION; NEUROMUSCULAR FUNCTION; PATHOPHYSIOLOGY; PEDIATRICS; PELLAGRA; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PREDICTOR VARIABLE; PREVALENCE; PROGNOSIS; REVIEW; RICHMOND AGITATION SEDATION SCALE; RISK ASSESSMENT; SEIZURE; SEPSIS; SEPSIS ENCEPHALOPATHY; TREATMENT INDICATION; UREMIA; WERNICKE ENCEPHALOPATHY; WITHDRAWAL SYNDROME;

BRAIN DAMAGE, CHRONIC; BRAIN DISEASES, METABOLIC; COMBINED MODALITY THERAPY; CRITICAL CARE; DELIRIUM; ENDOCRINE SYSTEM DISEASES; HEPATIC ENCEPHALOPATHY; HUMANS; INTENSIVE CARE UNITS; LIFE SUPPORT CARE; MALNUTRITION; METABOLISM, INBORN ERRORS; NEUROIMAGING; NEUROLOGIC EXAMINATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; SEPSIS; SEVERITY OF ILLNESS INDEX; WATER-ELECTROLYTE IMBALANCE;

EID: 84862156400     PISSN: 10802371     EISSN: 15386899     Source Type: Journal    
DOI: 10.1212/01.CON.0000415431.07019.c2     Document Type: Review

References (72)

1. Kiely DK, Bergmann MA, Murphy KM, et al. Delirium among newly admitted postacute facility patients: Prevalence, symptoms, and severity. J Gerontol A Biol Sci Med Sci 2003;58(5):M441-M445.
2. Francis J. Delirium in older patients. J Am Geriatr Soc 1992;40(8):829-838.
3. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291(14):1753-1762.
4. Frontera JA, Kalb T. Neurological management of fulminant hepatic failure. Neurocrit Care 2011;14(2):318-327.
5. Albrecht J, Norenberg MD. Glutamine: A Trojan horse in ammonia neurotoxicity. Hepatology 2006;44(4):788-794.
6. Larsen FS, Gottstein J, Blei AT. Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J Hepatol 2001;34(4):548-554.
7. Strauss G, Hansen BA, Kirkegaard P, et al. Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure. Hepatology 1997;25(4):837-839.
8. Jalan R, Olde Damink SW, Hayes PC, et al. Pathogenesis of intracranial hypertension in acute liver failure: Inflammation, ammonia and cerebral blood flow. J Hepatol 2004; 41(4):613-620.
9. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137(12): 947-954.
10. Raschke RA, Curry SC, Rempe S, et al. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med 2008;36(8):2244-2248.
11. Munoz SJ, Robinson M, Northrup B, et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 1991; 13(2):209-212.
12. Stravitz RT, Kramer AH, Davern T, et al. Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007;35(11):2498-2508.
13. Bacher A. Intracranial hypertension in fulminant hepatic failure. Transplant Proc 2006;38(3):783-785.
14. Blei AT, Olafsson S, Webster S, et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;341(8838):157-158.
15. Gray WP, Palmer JD, Gill J, et al. A clinical study of parenchymal and subdural miniature strain-gauge transducers for monitoring intracranial pressure. Neurosurgery 1996;39(5):927-931; discussion 931-932.
16. Figaji AA, Zwane E, Fieggen AG, et al. Transcranial Doppler pulsatility index is not a reliable indicator of intracranial pressure in children with severe traumatic brain injury. Surg Neurol 2009;72(4):389-394.
17. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358(20):2127-2137.
18. Makris M. Optimisation of the prothrombin complex concentrate dose for warfarin reversal. Thromb Res 2005;115(6):451-453.
19. Munoz SJ, Ballas SK, Moritz MJ, et al. Perioperative management of fulminant and subfulminant hepatic failure with therapeutic plasmapheresis. Transplant Proc 1989;21(3):3535-3536.
20. Caraceni P, Van Thiel DH. Acute liver failure. Lancet 1995;345(8943):163-169.
21. Sen S, Rose C, Ytrebo LM, et al. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: A randomized study. Crit Care Med 2006;34(1): 158-164.
22. Felipo V, Butterworth RF. Mitochondrial dysfunction in acute hyperammonemia. Neurochem Int 2002;40(6):487-491.
23. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial. Hepatology 2000;32(3):536-541.
24. Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failureVa controlled clinical trial. J Hepatol 2004;41(1): 89-96.
25. Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004;62(10):1743-1748.
26. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54(2):340-345.
27. Oddo M, Carrera E, Claassen J, et al. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009;37(6):2051-2056.
28. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009;137(3):856-864.
29. O'Grady JG, Alexander GJ, Hayllar KM, et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97(2):439-445.
30. Fraser C. Neurologic manifestations of the uremic state. Boston, MA: Little Brown, 1992.
31. Khatri M, Wright CB, Nickolas TL, et al. Chronic kidney disease is associated with white matter hyperintensity volume: The Northern Manhattan Study (NOMAS). Stroke 2007;38(12):3121-3126.
32. Kumar G, Goyal MK. Lentiform Fork sign: A unique MRI picture. Is metabolic acidosis responsible? Clin Neurol Neurosurg 2010; 112(9):805-812.
33. Yoon CH, Seok JI, Lee DK, et al. Bilateral basal ganglia and unilateral cortical involvement in a diabetic uremic patient. Clin Neurol Neurosurg 2009;111(5):477-479.
34. Young GB, Bolton CF, Austin TW, et al. The encephalopathy associated with septic illness. Clin Invest Med 1990;13(6):297-304.
35. Iacobone E, Bailly-Salin J, Polito A, et al. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009; 37(10 suppl):S331-S336.
36. Nguyen DN, Spapen H, Su F, et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 2006;34(7): 1967-1974.
37. Sharshar T, Annane D, de la Grandmaison GL, et al. The neuropathology of septic shock. Brain Pathol 2004;14(1):21-33.
38. Sharshar T, Carlier R, Bernard F, et al. Brain lesions in septic shock: A magnetic resonance imaging study. Intensive Care Med 2007; 33(5):798-806.
39. Eidelman LA, Putterman D, Putterman C, et al. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 1996;275(6):470-473.
40. Young GB, Bolton CF, Archibald YM, et al. The electroencephalogram in sepsis-associated encephalopathy. J Clin Neurophysiol 1992;9(1):145-152.
41. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355(20):2099-2112.
42. Zeltser D, Rosansky S, van Rensburg H, et al. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007;27(5):447-457.
43. Wijdicks EF, Vermeulen M, Murray GD, et al. The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 1990; 92(2):111-117.
44. Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: How high is too high? J Crit Care 2006;21(2):163-172.
45. Moder KG, Hurley DL. Fatal hypernatremia from exogenous salt intake: Report of a case and review of the literature. Mayo Clin Proc 1990;65(12):1587-1594.
46. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: A retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986;49(4):341-345.
47. Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: Identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997;62(1):51-60.
48. Skullerud K, Andersen SN, Lundevall J. Cerebral lesions and causes of death in male alcoholics. A forensic autopsy study. Int J Legal Med 1991;104(4):209-213.
49. Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci 1982; 56(2-3):233-248.
50. Cook CC, Hallwood PM, Thomson AD. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998;33(4):317-336.
51. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001;286(21): 2703-2710.
52. Frontera JA. Delirium and sedation in the ICU. Neurocrit Care 2011;14(3):463-474.
53. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166(10):1338-1344.
54. Francis J. Drug-induced delirium: Diagnosis and treatment. Auckland, New Zealand: Mairangi Bay, 1996.
55. Benbadis SR, Sila CA, Cristea RL. Mental status changes and stroke. J Gen Intern Med 1994;9(9):485-487.
56. Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: A factor in progressive midline shift and outcome. Neurology 2003;60(9):1441-1446.
57. Alberts VP, Bos MJ, Koudstaal PJ, et al. Heart failure and the risk of stroke: The RotterdamStudy. Eur J Epidemiol 2010;25(11): 807-812.
58. Salerno D, Marik PE, Daskalakis C, et al. The role of head computer tomographic scans on the management of MICU patients with neurological dysfunction. J Intensive Care Med 2009;24(6):372-375.
59. Kolls BJ, Husain AM. Assessment of hairline EEG as a screening tool for nonconvulsive status epilepticus. Epilepsia 2007;48(5): 959-965.
60. Warshaw G, Tanzer F. The effectiveness of lumbar puncture in the evaluation of delirium and fever in the hospitalized elderly. Arch Fam Med 1993;2(3):293-297.
61. Hopkins RO, Jackson JC. Long-term neurocognitive function after critical illness. Chest 2006;130(3):869-878.
62. Jackson JC, Hart RP, Gordon SM, et al. Six-month neuropsychological outcome of medical intensive care unit patients. Crit Care Med 2003;31(4):1226-1234.
63. Sharma P, Eesa M, Scott JN. Toxic and acquired metabolic encephalopathies: MRI appearance. AJR Am J Roentgenol 2009; 193(3):879-886.
64. Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301(15):1565-1572.
65. Inouye SK, Rushing JT, Foreman MD, et al. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 1998;13(4):234-242.
66. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009;301(5):489-499.
67. Shehabi Y, Riker RR, Bokesch PM, et al. Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010;38(12):2311-2318.
68. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): A randomised controlled trial. Lancet 2008;371(9607):126-134.
69. Girard TD, Jackson JC, Pandharipande PP, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010;38(7): 1513-1520.
70. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997; 336(4):251-257.
71. Adelow C, Andersson T, Ahlbom A, et al. Prior hospitalization for stroke, diabetes, myocardial infarction, and subsequent risk of unprovoked seizures. Epilepsia 2011; 52(2):301-307.
72. Morandi A, Gunther ML, Vasilevskis EE, et al. Neuroimaging in delirious intensive care unit patients: A preliminary case series report. Psychiatry (Edgmont) 2010;7(9):28-33.